ClassID:

21461

A61K49/0428 - CPC Classification

Classification description:

Preparations for testing; X-ray contrast preparations; Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound; Particles, beads, capsules or spheres; Nanoparticles, nanobeads, nanospheres, nanocapsules, i.e. having a size or diameter smaller than 1 micrometer Surface-modified nanoparticles, e.g. immuno-nanoparticles

Recent Application in this class:
#1
20250241871
2025-07-31

METHOD FOR MAKING A CURCUMINOID-CONTAINING DRUG DELIVERY COMPOSITION

#2
20240226341
2024-07-11

Dispersion Solution for X-Ray Target, Prefilled Syringe Filled with Same, and Powder for X-Ray Target

#3
20240131202
2024-04-25

Dispersion Solution for X-Ray Target, Prefilled Syringe Filled with Same, and Powder for X-Ray Target

#4
20240100197
2024-03-28

Method for making superparamagnetic iron oxide nanocarrier

#5
20230390419
2023-12-07

Equilibrium adsorption method for making a silica nanocarrier spion composition

#6
20230068832
2023-03-02

Curcuminoid chemotherapeutic drug carrier composition

#7
20230046343
2023-02-16

Method for treating breast cancer with a chemotherapeutic drug carrier

#8
20220296732
2022-09-22

Nanoparticle-alginate gels for X-ray imaging of the vasculature

#9
20220257801
2022-08-18

PARTICULATE STRUCTURES MADE FROM GOLD NANOPARTICLES, METHODS FOR PREPARING SAME AND USES THEREOF FOR TREATING SOLID TUMOURS

#10
20220048788
2022-02-17

Tantalum oxide nanoparticle contrast agents

#11
20210395182
2021-12-23

Modified chromium-doped zinc gallate nanocube, its preparation method and uses thereof

#12
20210353779
2021-11-18

Gold nanoparticle-ligand conjugates and methods of use

#13
20210322580
2021-10-21

Nanosilica carrier with spions and a curcuminoid

#14
20210138088
2021-05-13

BISMUTH-IRON OXIDE CONTRAST AGENTS

#15
20200390904
2020-12-17

ANTI-NUCLEOLIN AGENT-CONJUGATED NANOPARTICLES AS RADIO-SENSITIZERS AND MRI AND/OR X-RAY CONTRAST AGENTS

#16
20200215207
2020-07-09

Biospecific agents for bone

#17
20200179539
2020-06-11

Contrast Agents and Methods of Making the Same for Spectral CT That Exhibit Cloaking and Auto-Segmentation

#18
20200038525
2020-02-06

Curcumin-based magnetic nanostructured system for dual response of imaging and therapeutics

#19
20190054193
2019-02-21

Activity based probe and uses thereof for imaging

#20
20190015526
2019-01-17

Hybrid membrane-coated nanoparticle composites and methods of making and using the same

#21
20180360767
2018-12-20

BIOCOMPATIBLE PARTICLES AND METHODS OF MAKING AND USE THEREOF

#22
20180353612
2018-12-13

Pharmaceutical composition and methods for using the same

#23
20180271978
2018-09-27

Biomaterials for combined radiotherapy and immunotherapy of cancer

#24
20180264144
2018-09-20

High-resolution optical molecular imaging systems, compositions, and methods

#25
20180238908
2018-08-23

NEURODEGENERATIVE DISORDERS

#26
20180236106
2018-08-23

RADIOGRAPHIC NANOPARTICLE CONTRAST AGENTS FOR DUAL-ENERGY X-RAY IMAGING AND COMPUTED TOMOGRAPHY SCANNING AND METHODS OF USING THEREOF

#27
20180214104
2018-08-02

Nano particle detection with X-ray capsule

#28
20180200385
2018-07-19

Anti-nucleolin agent-conjugated nanoparticles as radio-sensitizers and MRI and/or X-ray contrast agents

#29
20180028833
2018-02-01

Recombinant self-assembling protein comprising target-oriented peptide and use thereof

#30
20170000910
2017-01-05

Polyphosphazene delivery system for inorganic nanocrystals

#31
20160274086
2016-09-22

Methods compositions and kits for imaging cells and tissues using nanoparticles and spatial frequency heterodyne imaging

#32
20160271274
2016-09-22

SYNTHESIS AND USE OF TARGETED RADIATION ENHANCING IRON OXIDE-SILICA-GOLD NANOSHELLS FOR IMAGING AND TREATMENT OF CANCER

#33
20160074511
2016-03-17

Recombinant self-assembling protein comprising target-oriented peptide and use thereof

#34
20160038617
2016-02-11

Treating water insoluble nanoparticles with hydrophilic alpha-hydroxyphosphonic acid conjugates, the so modified nanoparticles and their use as contrast agents

#35
20150258034
2015-09-17

Gold/lanthanide nanoparticle conjugates and uses thereof

#36
20150250902
2015-09-10

pH-RESPONSIVE GADOLINIUM NANOPARTICLE CONJUGATES AND USES THEREOF

#37
20150164803
2015-06-18

Magnetic iron oxide fine particles, and magnetic particle-containing water dispersion and process for producing the same

#38
20150139912
2015-05-21

CT contrast medium for detecting thrombus, comprising fibrin-targeted peptide sequence-conjugated glycol chitosan-gold nanoparticles

#39
20140349004
2014-11-27

DTPA DERIVATIVE, METAL COMPLEX, MR AND CT CONTRAST AGENT AND METHOD FOR MANUFACTURING SAME

#40
20140219922
2014-08-07

Use of scintillator-based nanoparticles for in vivo control of light-sensitive bioactive molecules

#41
20140147387
2014-05-29

Nanoparticle contrast agents for diagnostic imaging

#42
20140056821
2014-02-27

Nanoparticulate compositions for diagnostic imaging

#43
20140056819
2014-02-27

Nanoparticulate compositions for diagnostic imaging

#44
20130323311
2013-12-05

Collagen-targeted nanoparticles

#45
20130216588
2013-08-22

Insulin-gold nanocluster, pharmaceutical composition for reducing blood glucose comprising the same, and method for detecting adipose cells in tissue by using the same

#46
20130095499
2013-04-18

Methods, compositions and kits for imaging cells and tissues using nanoparticles and spatial frequency heterodyne imaging

#47
20130065995
2013-03-14

Surface-modified tantalum oxide nanoparticles, preparation method thereof, and contrast medium for X-ray computed tomography and highly dielectric thin film using same

#48
20130017155
2013-01-17

DUAL CT/MRI NANOPARTICLE CONTRAST AGENT

#49
20120269896
2012-10-25

MAGNETIC IRON OXIDE FINE PARTICLES, AND MAGNETIC PARTICLE-CONTAINING WATER DISPERSION AND PROCESS FOR PRODUCING THE SAME

#50
20120128583
2012-05-24

DTPA DERIVATIVE, METAL COMPLEX, MR AND CT CONTRAST AGENT AND METHOD FOR MANUFACTURING SAME

#51
20120076737
2012-03-29

Method of using CT/MRI dual modality contrast agent

#52
20120052006
2012-03-01

Gold/lanthanide nanoparticle conjugates and uses thereof

#53
20110300532
2011-12-08

CONTROL OF THE TOXICITY OF GOLD NANOPARTICLES

#54
20110110858
2011-05-12

Gold nanoparticle imaging agents and uses thereof

#55
20110104072
2011-05-05

Treating water insoluble nanoparticles with hydrophilic alpha-hydroxyphosphonic acid conjugates, the so modified nanoparticles and their use as contrast agents

#56
20110064674
2011-03-17

LUMINESCENT MULTIMODAL NANOPARTICLE PROBE SYSTEM AND METHOD OF MANUFACTURE THEREOF

#57
20110044900
2011-02-24

METHOD FOR TREATING AND/OR DIAGNOSING TUMOR BY GOLD PARTICLES COATED WITH A POLYMER

#58
20100297019
2010-11-25

Particles for imaging

#59
20100278749
2010-11-04

NANOPARTICLE CONTRAST AGENTS FOR DIAGNOSTIC IMAGING

#60
20100278748
2010-11-04

NANOPARTICLE CONTRAST AGENTS FOR DIAGNOSTIC IMAGING

#61
20100278734
2010-11-04

NANOPARTICLE CONTRAST AGENTS FOR DIAGNOSTIC IMAGING

#62
20100266508
2010-10-21

Stabilized gold nanoparticle and contrast agent

#63
20100215586
2010-08-26

Method for preparing nanoparticles covered with a gem-bisphosphonate stabilizing layer coupled to hydrophilic distribution ligands

#64
20100166666
2010-07-01

Nanoparticle contrast agents for diagnostic imaging

#65
20100166665
2010-07-01

Nanoparticle contrast agents for diagnostic imaging

#66
20100166664
2010-07-01

NANOPARTICLE CONTRAST AGENTS FOR DIAGNOSTIC IMAGING

#67
20100074848
2010-03-25

X-ray contrast agent using gold nanoparticles and process for preparing the same

#68
20100041789
2010-02-18

Radiopaque infiltrant

#69
20090263331
2009-10-22

Multifunction nanoconjugates for imaging applications and targeted treatment

#70
20090208417
2009-08-20

Detection and Localized Imaging of Cancer Using X-Ray Fluorescent Nanoparticle/Preferential Locator Conjugates

#71
20080089836
2008-04-17

Functional associative coatings for nanoparticles

#72
20070274909
2007-11-29

Radiation Therapy and Medical Imaging Using Uv Emitting Nanoparticles

#73
20070258888
2007-11-08

Contrast Agent for Medical Imaging Techniques and Usage Thereof

#74
20070218009
2007-09-20

Lanthanide rich nanoparticles, and their investigative uses in MRI and related technologies

#75
20070051202
2007-03-08

Methods and articles for gold nanoparticle production

#76
20070031339
2007-02-08

Contrast agents

#77
20070031337
2007-02-08

Nanoparticle enhanced proton computed tomography and proton therapy

#78
20060222595
2006-10-05

Nanoparticles for therapeutic and diagnostic applications

#79
20060014938
2006-01-19

Stable aqueous colloidal lanthanide oxides

#80
20050287216
2005-12-29

Medical imaging agents for injectable compositions